Caenorhabditis elegans immune conditioning with the probiotic bacterium Lactobacillus acidophilus strain ncfm enhances gram-positive immune responses

Infection and Immunity

Volumn 80, Issue 7, 2012, Pages 2500-2508

  Kim, Younghoon ^b   Mylonakis, Eleftherios ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BAR 1 PROTEIN; BETA CATENIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PMK 1 PROTEIN; PROBIOTIC AGENT; TIR 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACILLUS SUBTILIS; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DRUG EFFICACY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECALIS INFECTION; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE; LACTOBACILLUS ACIDOPHILUS; MEDIATOR; MULTIDRUG RESISTANCE; NEMATODE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE;

ANIMALS; BACILLUS SUBTILIS; CAENORHABDITIS ELEGANS; ENTEROCOCCUS FAECALIS; GASTROINTESTINAL TRACT; LACTOBACILLUS ACIDOPHILUS; PROBIOTICS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

EID: 84864827343     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06350-11     Document Type: Article

References (48)

1. Aballay A, Yorgey P, Ausubel FM. 2000. Salmonella typhimurium proliferates and establishes a persistent infection in the intestine of Caenorhabditis elegans. Curr. Biol. 10, 1539-1542.
2. Altermann E, et al. 2005. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc. Natl. Acad. Sci. U. S. A. 102, 3906-3912.
3. Anyanful A, Easley KA, Benian GM, Kalman D. 2009. Conditioning protects C. elegans from lethal effects of enteropathogenic E. coli by activating genes that regulate lifespan and innate immunity. Cell Host Microbe 5, 450-462.
4. Baba T, et al. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359, 1819-1827.
5. Breger J, et al. 2007. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 3, e18. doi, 10.1371/ journal.ppat.0030018.
6. Couillault C, et al. 2004. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat. Immunol. 5, 488-494.
7. Donegan K, Matyac C, Seidler R, Porteous A. 1991. Evaluation of methods for sampling, recovery, and enumeration of bacteria applied to the phylloplane. Appl. Environ. Microbiol. 57, 51-56.
8. Garsin DA, et al. 2001. A simple model host for identifying Grampositive virulence factors. Proc. Natl. Acad. Sci. U. S. A. 98, 10892-10897.
9. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. 2001. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 74, 833-839.
10. Hsu A-L, Murphy CT, Kenyon C. 2003. Regulation of aging and agerelated disease by DAF-16 and heat-shock factor. Science 300, 1142-1145.
11. Ikeda T, Yasui C, Hoshino K, Arikawa K, Nishikawa Y. 2007. Influence of lactic acid bacteria on longevity of Caenorhabditis elegans and host defense against Salmonella enterica serovar Enteritidis. Appl. Environ. Microbiol. 73, 6404-6409.
12. Irazoqui JE, Ng A, Xavier RJ, Ausubel FM. 2008. Role for _-catenin and HOXtranscription factors in Caenorhabditis elegans and mammalian host epithelial-pathogen interactions. Proc. Natl. Acad. Sci. U. S. A. 105, 17469-17474.
13. Irazoqui JE, et al. 2010. Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathog. 6, e1000982. doi, 10.1371/journal.ppat.1000982.
14. Irazoqui JE, Urbach JM, Ausubel FM. 2010. Evolution of host innate defence, insights from Caenorhabditis elegans and primitive invertebrates. Nat. Rev. Immunol. 10, 47-58.
15. Kim DH, et al. 2002. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297, 623-626.
16. Kim Y, Oh S, Kim SH. 2009. Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157, H7. Biochem. Biophys. Res. Commun. 379, 324-329.
17. Kim Y, Oh S, Yun HS, Kim SH. 2010. Cell-bound exopolysaccharide from probiotic bacteria induces autophagic cell death of tumour cells. Lett. Appl. Microbiol. 51, 123-130.
18. Konstantinov SR, et al. 2008. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl. Acad. Sci. U. S. A. 105, 19474-19479.
19. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. 2010. Host interactions of probiotic bacterial surface molecules, comparison with commensals and pathogens. Nat. Rev. Micro. 8, 171-184.
20. Lee J, Jayaraman A, Wood T. 2007. Indole is an inter-species biofilm signal mediated by SdiA. BMC Microbiol. 7, 42.
21. Lee KZ, Kniazeva M, Han M, Pujol N, Ewbank JJ. 2010. The fatty acid synthase fasn-1 acts upstream of WNK and Ste20/GCK-VI kinases to modulate antimicrobial peptide expression in C. elegans epidermis. Virulence 1, 113-122.
22. Liberati NT, et al. 2004. Requirement for a conserved Toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response. Proc. Natl. Acad. Sci. U. S. A. 101, 6593-6598.
23. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2___CT method. Methods 25, 402-408.
24. Matsuzaki T, Chin J. 2000. Modulating immune responses with probiotic bacteria. Immunol. Cell Biol. 78, 67-73.
25. Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449, 819-826.
26. Metchnikoff E. 1907. The prolongation of life, optimistic studies. Heinemann, London, United Kingdom.
27. Moy TI, et al. 2006. Identification of novel antimicrobials using a liveanimal infection model. Proc. Natl. Acad. Sci. U. S. A. 103, 10414-10419.
28. Murphy CT, et al. 2003. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277-283.
29. Paulsen IT, et al. 2003. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299, 2071-2074.
30. Plantinga TS, et al. 2011. Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics. Clin. Vaccine Immunol. 18, 621-628.
31. Powell JR, Kim DH, Ausubel FM. 2009. The G protein-coupled receptor FSHR-1 is required for the Caenorhabditis elegans innate immune response. Proc. Natl. Acad. Sci. U. S. A. 106, 2782-2787.
32. Pujol N, et al. 2001. A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr. Biol. 11, 809-821.
33. Pukkila-Worley R, Ausubel FM, Mylonakis E. 2011. C. albicans infection of Caenorhabditis elegans induces antifungal immune defenses. PLoS Pathog. 7, e1002074. doi, 10.1371/journal.ppat.1002074.
34. Reid G, et al. 2011. Microbiota restoration, natural and supplemented recovery of human microbial communities. Nat. Rev. Microbiol. 9, 27-38.
35. Shivers RP, et al. 2010. Phosphorylation of the conserved transcription factor ATF-7 by PMK-1 p38 MAPK regulates innate immunity in Caenorhabditis elegans. PLoS Genet. 6, e1000892. doi, 10.1371/journal. pgen.1000892.
36. Sifri CD, Begun J, Ausubel FM. 2005. The worm has turned-microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol. 13, 119-127.
37. So S, Tokumaru T, Miyahara K, Ohshima Y. 2011. Control of lifespan by food bacteria, nutrient limitation and pathogenicity of food in C. elegans. Mech. Ageing Dev. 132, 210-212.
38. Tan M-W, Mahajan-Miklos S, Ausubel FM. 1999. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 96, 715-720.
39. Tenor JL, Aballay A. 2008. A conserved Toll-like receptor is required for Caenorhabditis elegans innate immunity. EMBO Rep. 9, 103-109.
40. Thomas CM, Versalovic J. 2010. Probiotics-host communication, modulation of signaling pathways in the intestine. Gut Microbes 1, 148-163.
41. Troemel ER, et al. 2006. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2, e183. doi, 10.1371/journal.pgen.0020183.
42. Vance RE, Isberg RR, Portnoy DA. 2009. Patterns of pathogenesis, discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 6, 10-21.
43. Wang C, et al. 2011. Use of Caenorhabditis elegans for preselecting Lactobacillus isolates to control Salmonella Typhimurium. J. Food Prot. 74, 86-93.
44. Wang X, Wang X, Li L, Wang D. 2010. Lifespan extension in Caenorhabditis elegans by DMSO is dependent on sir-2.1 and daf-16. Biochem. Biophys. Res. Commun. 400, 613-618.
45. Wells JM, Mercenier A. 2008. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat. Rev. Microbiol. 6, 349-362.
46. Wong D, Bazopoulou D, Pujol N, Tavernarakis N, Ewbank J. 2007. Genome-wide investigation reveals pathogen-specific and shared signatures in the response of Caenorhabditis elegans to infection. Genome Biol. 8, R194.
47. Zhang Y, Lu H, Bargmann CI. 2005. Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans. Nature 438, 179-184.
48. Zugasti O, Ewbank JJ. 2009. Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-_ signaling pathway in Caenorhabditis elegans epidermis. Nat. Immunol. 10, 249-256.